COMMUNIQUÉS West-GlobeNewswire

Sutro Biopharma Announces Initiation of REFRαME-L1 Phase 2 Trial with Luvelta for Patients with Non-Small Cell Lung Cancer

22/08/2024 - 14:00

SOUTH SAN FRANCISCO, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug [...]

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

21/08/2024 - 22:30

NOVATO, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare [...]

Integra LifeSciences Continues to Make Progress on Its ESG Strategy

21/08/2024 - 22:15

The company published its third ESG report, underscoring its values and commitment to restoring lives PRINCETON, N.J., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Company (NASDAQ: IART), a leading [...]

Certara to Participate in Upcoming Investor Conferences

21/08/2024 - 22:15

RADNOR, Pa., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor [...]

Globus Medical Launches ADIRA™ XLIF™ Plate System

21/08/2024 - 22:15

AUDUBON, Pa., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the commercial launch of the ADIRA™ XLIF™ Plate System, the Company’s first [...]

Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment

21/08/2024 - 22:11

Vancouver, Canada, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]

LifeStance to Present at the 22nd Annual Morgan Stanley Healthcare Conference

21/08/2024 - 22:10

SCOTTSDALE, Ariz., Aug. 21, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will present at [...]

Guardion Health Sciences Declares Cash Dividend of $5.00 Per Share of Common Stock

21/08/2024 - 22:05

HOUSTON, TEXAS, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) today announced that its Board of Directors declared a cash dividend in an amount equal to $5 [...]

Inari Medical to Present at Upcoming Investor Conferences

21/08/2024 - 22:05

IRVINE, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other [...]

Clover Health to Participate in Upcoming 2024 Wells Fargo Healthcare Conference

21/08/2024 - 22:05

FRANKLIN, Tenn., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to [...]

Inspire Medical Systems, Inc. to Present at Upcoming Investor Conferences

21/08/2024 - 22:02

MINNEAPOLIS, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive [...]

SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX®

21/08/2024 - 22:00

NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company and leader in infectious diseases, today announced a new contract with the U.S. [...]

MDxHealth Reports Q2 and Half Year 2024 Results

21/08/2024 - 22:00

MDxHealth Reports Q2 and Half Year 2024 Results Year-over-year Q2 revenues increase by 32% to $22.2 million Year-over-year H1 revenues increase by 34% to 42.0 million Conference call with Q&A today at 4:30 PM ET / [...]

Le KFSHRC présente ses innovations en matière d’éducation médicale à l’occasion de la conférence AMEE 2024, organisée en Suisse

21/08/2024 - 21:54

RIYAD, Arabie saoudite, 21 août 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSHRC) poursuit l’expansion de son empreinte mondiale en participant à l’édition 2024 de la conférence [...]

ProLynx announces preclinical results of long-acting semaglutide requiring once monthly dosing

21/08/2024 - 20:16

SAN FRANCISCO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- ProLynx Inc. today announced the use of their technology to create a long-acting semaglutide that can be administered once monthly. The ProLynx technology involves [...]

Bavarian Nordic Receives 440,000 Dose Contract to Supply Smallpox and Mpox Vaccines for Undisclosed European Country

21/08/2024 - 19:30

The order was anticipated as part of the 2024 guidance and has no impact on the remaining 2024/25 capacity for the Company’s smallpox and mpox vaccine. COPENHAGEN, Denmark, August 21, 2024 – Bavarian Nordic A/S (OMX: [...]

Orion Corporation: Managers’ transactions – Niclas Lindstedt

21/08/2024 - 17:45

ORION CORPORATION MANAGERS’ TRANSACTIONS 21 AUGUST 2024 at 18.45 EEST Orion Corporation: Managers’ transactions – Niclas Lindstedt Orion Corporation has received the following disclosure under Market Abuse Regulation ( [...]

AiM Medical Robotics Announces Co-Founder Dr. Julie Pilitsis Elected as President of the American Society for Stereotactic and Functional Neurosurgery

21/08/2024 - 17:28

— New role underscores Dr. Pilitsis’s leadership in advancing neurosurgical techniques and precision-guided robotics — WORCESTER, Mass., Aug. 21, 2024 (GLOBE NEWSWIRE) -- AiM Medical Robotics Inc. (AiM), a leading [...]

Kymera Therapeutics Announces Closing of Upsized $225 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

21/08/2024 - 17:15

WATERTOWN, Mass., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein [...]